Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses.
The company is working with an adviser to find potential buyers for the Nicotinell brand, which includes nicotine gum, patches, and lozenges.
The Nicotinell brand’s sale, which draws interest from investment firms and consumer companies, could be valued as high as $800 million.
Previously, Haleon also considered selling its ChapStick lip balm brand, which could potentially bring in about $600 million.
Among the brands owned …
